These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 25673194
1. Fenofibrate pre-treatment suppressed inflammation by activating phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling in renal ischemia-reperfusion injury. Yang FJ, He YH, Zhou JH. J Huazhong Univ Sci Technolog Med Sci; 2015 Feb; 35(1):58-63. PubMed ID: 25673194 [Abstract] [Full Text] [Related]
2. Protective effect of Fenofibrate in renal ischemia reperfusion injury: Involved in suppressing kinase 2 (JAK2)/transcription 3 (STAT3)/p53 signaling activation. Lv J, Wang X, Liu SY, Liang PF, Feng M, Zhang LL, Xu AP. Pathol Biol (Paris); 2015 Dec; 63(6):236-42. PubMed ID: 26343046 [Abstract] [Full Text] [Related]
3. Erythropoietin pretreatment ameliorates renal ischaemia-reperfusion injury by activating PI3K/Akt signalling. Zhang J, Zou YR, Zhong X, Deng HD, Pu L, Peng K, Wang L. Nephrology (Carlton); 2015 Apr; 20(4):266-72. PubMed ID: 25581532 [Abstract] [Full Text] [Related]
4. Propofol can suppress renal ischemia-reperfusion injury through the activation of PI3K/AKT/mTOR signal pathway. Wei Q, Zhao J, Zhou X, Yu L, Liu Z, Chang Y. Gene; 2019 Aug 05; 708():14-20. PubMed ID: 31082504 [Abstract] [Full Text] [Related]
5. Protective effects of epigallocatechin-3-gallate on intestinal ischemia reperfusion injury through enhanced activation of PI3K/Akt pathway in rats. Zhang X, He F, Yang J, Chen ZS. J Huazhong Univ Sci Technolog Med Sci; 2015 Jun 05; 35(3):378-383. PubMed ID: 26072077 [Abstract] [Full Text] [Related]
6. The Protective Role of Celastrol in Renal Ischemia-Reperfusion Injury by Activating Nrf2/HO-1, PI3K/AKT Signaling Pathways, Modulating NF-κb Signaling Pathways, and Inhibiting ERK Phosphorylation. Younis NS, Ghanim AMH. Cell Biochem Biophys; 2022 Mar 05; 80(1):191-202. PubMed ID: 35157199 [Abstract] [Full Text] [Related]
7. Catalpol protects mice against renal ischemia/reperfusion injury via suppressing PI3K/Akt-eNOS signaling and inflammation. Zhu J, Chen X, Wang H, Yan Q. Int J Clin Exp Med; 2015 Mar 05; 8(2):2038-44. PubMed ID: 25932134 [Abstract] [Full Text] [Related]
8. Protective Effects of Geniposide on Hepatic Ischemia/Reperfusion Injury. Rong YP, Huang HT, Liu JS, Wei L. Transplant Proc; 2017 Mar 05; 49(6):1455-1460. PubMed ID: 28736023 [Abstract] [Full Text] [Related]
9. Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway. Liang S, Wang Y, Liu Y. Eur Rev Med Pharmacol Sci; 2019 Jan 05; 23(1):370-377. PubMed ID: 30657579 [Abstract] [Full Text] [Related]
10. Remote ischemic postconditioning protects against renal ischemia/reperfusion injury by activation of T-LAK-cell-originated protein kinase (TOPK)/PTEN/Akt signaling pathway mediated anti-oxidation and anti-inflammation. Gao S, Zhu Y, Li H, Xia Z, Wu Q, Yao S, Wang T, Yuan S. Int Immunopharmacol; 2016 Sep 05; 38():395-401. PubMed ID: 27355132 [Abstract] [Full Text] [Related]
11. Protective effect of tea polyphenols on renal ischemia/reperfusion injury via suppressing the activation of TLR4/NF-κB p65 signal pathway. Li YW, Zhang Y, Zhang L, Li X, Yu JB, Zhang HT, Tan BB, Jiang LH, Wang YX, Liang Y, Zhang XS, Wang WS, Liu HG. Gene; 2014 May 25; 542(1):46-51. PubMed ID: 24630969 [Abstract] [Full Text] [Related]
12. Erythropoietin pretreatment suppresses inflammation by activating the PI3K/Akt signaling pathway in myocardial ischemia-reperfusion injury. Rong R, Xijun X. Exp Ther Med; 2015 Aug 25; 10(2):413-418. PubMed ID: 26622330 [Abstract] [Full Text] [Related]
13. Protective effects of pioglitazone on renal ischemia-reperfusion injury in mice. Hu H, Zou C, Xi X, Shi Z, Wang G, Huang X. J Surg Res; 2012 Nov 25; 178(1):460-5. PubMed ID: 22507688 [Abstract] [Full Text] [Related]
14. Pretreatment With Erythropoietin Attenuates Intestinal Ischemia Reperfusion Injury by Further Promoting PI3K/Akt Signaling Activation. Kai-lan W, Si Z. Transplant Proc; 2015 Nov 25; 47(6):1639-45. PubMed ID: 26293027 [Abstract] [Full Text] [Related]
15. Potential nephroprotective effects of angiotensin II type 2 receptor agonist Compound 21 in renal ischemia-reperfusion injury. Kadhim LF, Gany SN, Qassam H, Hadi NR, Kadhim S. J Med Life; 2023 Sep 25; 16(9):1428-1432. PubMed ID: 38107718 [Abstract] [Full Text] [Related]
16. Kappa-opioid receptor agonist U50448H protects against renal ischemia-reperfusion injury in rats via activating the PI3K/Akt signaling pathway. Liu LJ, Yu JJ, Xu XL. Acta Pharmacol Sin; 2018 Jan 25; 39(1):97-106. PubMed ID: 28770825 [Abstract] [Full Text] [Related]
17. Nicorandil protects against ischaemia-reperfusion injury in newborn rat kidney. Zhang YJ, Zhang AQ, Zhao XX, Tian ZL, Yao L. Pharmacology; 2013 Jan 25; 92(5-6):245-56. PubMed ID: 24247737 [Abstract] [Full Text] [Related]
18. Dexmedetomidine preconditioning inhibits the long term inflammation induced by renal ischemia/reperfusion injury in rats. Liu G, Song H, Qiu L, He A, Tong F, Wan Q, Wang X, Xia Y, Huang L. Acta Cir Bras; 2016 Jan 25; 31(1):8-14. PubMed ID: 26840350 [Abstract] [Full Text] [Related]
19. Attenuation of renal ischemic reperfusion injury by salvianolic acid B via suppressing oxidative stress and inflammation through PI3K/Akt signaling pathway. Ma ZG, Xia HQ, Cui SL, Yu J. Braz J Med Biol Res; 2017 May 15; 50(6):e5954. PubMed ID: 28513773 [Abstract] [Full Text] [Related]
20. Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and prostaglandin E2. Hwang HS, Yang KJ, Park KC, Choi HS, Kim SH, Hong SY, Jeon BH, Chang YK, Park CW, Kim SY, Lee SJ, Yang CW. Nephrol Dial Transplant; 2013 May 15; 28(5):1156-66. PubMed ID: 23229926 [Abstract] [Full Text] [Related] Page: [Next] [New Search]